UBS, Confronts

UBS Confronts a $22 Billion Regulatory Ultimatum

19.04.2026 - 16:44:52 | boerse-global.de

UBS Chairman warns of exploring 'other options' if Swiss capital rules proceed. New board appointments and Q1 results loom as parliament decides in May.

UBS Confronts a $22 Billion Regulatory Ultimatum - Foto: über boerse-global.de
UBS Confronts a $22 Billion Regulatory Ultimatum - Foto: über boerse-global.de

A stark warning from UBS leadership has escalated a simmering dispute with Swiss authorities into a public confrontation. Chairman Colm Kelleher stated the bank would be forced to explore "other options" to mitigate damage if the government proceeds with stringent new capital rules, though he ruled out shrinking the bank. The political showdown centers on a Federal Council proposal that UBS says would create an additional $22 billion capital requirement.

The core of the regulatory clash involves plans to exclude bank software and deferred tax assets from the calculation of high-quality Common Equity Tier 1 capital. Analysts at Bank of America suggest a potential compromise, where deferred tax assets could remain partially recognized up to a ten percent cap. Such a move would reduce the capital hit from intangible assets to $6.2 billion, a significant drop from the nearly $11 billion currently anticipated. The final decision rests with parliament in May, following warnings from economic committees last autumn that over-regulation risks crippling the financial sector's competitiveness.

Amid this political tension, shareholders recently endorsed a significant refresh of the bank's supervisory board. The appointments of Agustín Carstens, former head of the Bank for International Settlements, and ex-Apple CFO Luca Maestri signal a push for greater global perspective and financial expertise. Investors also confirmed the dividend of $1.10 per share for 2025, with the stock trading ex-dividend on April 21.

Should investors sell immediately? Or is it worth buying UBS?

The bank's operational strength faces a immediate test on April 29 with the release of first-quarter results. Analysts forecast earnings per share between $0.79 and $0.84 on revenue of approximately $11.7 billion. A key focus will be further stabilization of operating margins in the Wealth Management division and progress toward the bank's targeted 15 percent return on equity. The market will also watch for details on a previously announced share buyback program worth around $3 billion.

Beyond quarterly performance, a study commissioned by UBS from BAK Economics paints a grim macroeconomic picture should the strictest rules be implemented. The research warns of structurally higher credit costs, potentially reducing Swiss GDP by up to 3.9 percent over the next decade. The cumulative economic loss could reach 34 billion Swiss francs. With the stock recently trading at 34.33 Swiss francs, the coming weeks will determine whether UBS can navigate these regulatory headwinds or if political decisions will overshadow its financial trajectory. Deutsche Bank analysts maintain a buy rating with a fair value estimate of 39 francs.

Ad

UBS Stock: New Analysis - 19 April

Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated UBS analysis...

So schätzen die Börsenprofis UBS Aktien ein!

<b>So schätzen die Börsenprofis UBS Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | CH0244767585 | UBS | boerse | 69205458 |